Markets Digest Expected Fed Rate Cut With Modest Moves; Tech Slips on China Tensions

Markets mostly treaded water following the Federal Reserve’s well-telegraphed decision to cut interest rates by 25bps and signal two more cuts this year. The move marked the beginning of a long-anticipated easing cycle, but investor reaction was muted as most of the dovishness was already priced in. The S&P 500 ended marginally lower while the Dow gained, and Treasury yields rose modestly. Tech stocks underperformed amid renewed U.S.-China chip tensions, dragging the Nasdaq lower.

Key Headlines & Market Movers

• Fed Cuts 25bps Unsurprisingly, Signals Two More: The Fed delivered what markets expected: a 25bps rate cut and a dot plot that implies two more cuts before year-end. Chair Powell struck a cautious tone, citing rising risks to employment while reaffirming the Fed's commitment to the 2% inflation target. While the rate cut was unanimous save for one member seeking a deeper cut, Powell emphasized a “balanced” outlook rather than a full pivot. Market participants largely saw this as a defensive move to support labor markets, not an aggressive bid to reaccelerate growth.
• Market Reaction Muted as Easing Was Priced In: With easing well telegraphed since the soft July jobs report, the Fed’s decision landed without much fanfare. Stocks seesawed but closed mostly flat, with the S&P 500 off just 0.1%. Bond yields rose slightly, suggesting that the market had largely anticipated the move. Analysts noted a “buy the rumor, sell the news” feel to the day’s action, especially in a typically weak seasonal window like September.
• Tech Stocks Hit by China’s Nvidia Ban: Nvidia slid over 3.5% after reports surfaced that Chinese regulators ordered major domestic firms to halt purchases of its high-end AI chips. Broadcom and Palantir also fell sharply, dragging the Nasdaq 100 into negative territory. The development reignites concerns over tech decoupling and adds fresh geopolitical risk to the sector’s outlook.
• Corporate Highlights - StubHub, Workday, Eli Lilly: Workday surged 6% after Elliott Management disclosed a $2B stake, signaling activist involvement. StubHub's IPO stumbled post-debut, closing 5% lower despite an early pop. Meanwhile, Eli Lilly’s experimental diabetes drug outperformed an existing Novo Nordisk treatment in early trials, potentially expanding its lead in the fast-growing weight loss category.

S&P 500 Sector Performance

Looking Ahead

While the Fed’s dovish lean offers some reassurance, the path forward remains data-dependent. Investors will closely watch upcoming labor and inflation prints to gauge the timing and scope of further cuts. For now, equity markets appear to be consolidating recent gains while bonds may find support amid lingering economic uncertainty. Positioning for potential curve flattening and favoring intermediate bond maturities may offer the best balance in the current environment.